相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy
Tsunamasa Watanabe et al.
HEPATOLOGY RESEARCH (2013)
Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy
Yin-Hua Wang et al.
SUPPORTIVE CARE IN CANCER (2013)
Ruxolitinib for myelofibrosis therapy: current context, pros and cons
A. Pardanani
LEUKEMIA (2012)
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment
Hong Shi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection
Alessandro Zerbini et al.
GASTROENTEROLOGY (2008)
Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA
Robyn Puro et al.
JOURNAL OF VIROLOGY (2007)
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy
W Yeo et al.
HEPATOLOGY (2006)
分享论文
